Fulcrum Therapeutics Inc.’s (NASDAQ: FULC) shares are witnessing a remarkable ascent on the US market today, reflecting a surge of 13.39% during the pre-market session,
Fulcrum Therapeutics Inc. (FULC) recently presented new data and information regarding imaging biomarkers and clinical outcome assessments for facioscapulohumeral muscular dystrophy (FSHD). FULC stock closed $11.98 on 22nd March, increasing 5.46% compared to the $11.36 close
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.